|Development and validation of a simultaneous HPLC method for estimation of bisoprolol fumarate and amlodipine besylate from tablets.|
|Jump to Full Text|
|PMID: 20046793 Owner: NLM Status: PubMed-not-MEDLINE|
|A fast, robust and stability indicating RP-HPLC method was developed for simultaneous determination of bisoprolol fumarate and amlodipine besylate in tablets. The mobile phase was mixture of 25 mM ammonium acetate adjusted to pH 5.0 and methanol (65: 35) at 0.8 ml/min. The stationary phase was Luna C18-2 column (3 mu, 50x4.6 mm ID). UV detection was performed at 230 nm. Retention time was 1.45 min and 3.91 min for bisoprolol and amlodipine, respectively. Linearity was established in the range of 8-33 mug/ml. Mean recovery was 99.1% and 98.6% for bisoprolol fumarate and amlodipine besylate, respectively.|
|D N Vora; A A Kadav|
Related Documents :
|24183433 - Iron(iii) extraction from chloride media by n,n'-tetrasubstituted malonamides: an inter...
24579303 - Stability of nitroglycerin 110 mcg/ml stored in polypropylene syringes.
23537833 - A photochemical method for improvement of color stability at polymer-wood biointerfaces.
|Type: Journal Article|
|Title: Indian journal of pharmaceutical sciences Volume: 70 ISSN: 1998-3743 ISO Abbreviation: Indian J Pharm Sci Publication Date: 2008 Jul-Aug|
|Created Date: 2010-01-04 Completed Date: 2011-07-14 Revised Date: 2013-05-29|
Medline Journal Info:
|Nlm Unique ID: 7809431 Medline TA: Indian J Pharm Sci Country: India|
|Languages: eng Pagination: 542-6 Citation Subset: -|
|Chemistry Dept, Mithibai college of Arts, Chauhan Institute of Science and A. J. College of Commerce and Economics, Vile Parle (W), Mumbai-400 056, India.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Indian J Pharm Sci
Journal ID (publisher-id): IJPhS
Publisher: Medknow Publications, India
? Indian Journal of Pharmaceutical Sciences
Accepted Day: 25 Month: 8 Year: 2008
Revision Received Day: 04 Month: 2 Year: 2008
Received Day: 03 Month: 4 Year: 2007
Print publication date: Season: Jul?Aug Year: 2008
Volume: 70 Issue: 4
First Page: 542 Last Page: 546
PubMed Id: 20046793
Publisher Id: IJPhS-70-542
|Development and Validation of a Simultaneous HPLC Method for Estimation of Bisoprolol Fumarate and Amlodipine Besylate from Tablets|
|D. N. Vora*AF0001|
|A. A. KadavAF0001|
|Chemistry Dept, Mithibai college of Arts, Chauhan Institute of Science and A. J. College of Commerce and Economics, Vile Parle (W), Mumbai-400 056, India
|*For correspondence E-mail: email@example.com
[other] Vora, et al.: Simultaneous HPLC Method for Bisoprolol Fumarate and Amlodipine Besylate
Bisoprolol fumarate is a synthetic beta1 -selective cardioselective adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is (?)-1-[4-[[2-(1-methylethoxy) ethoxy] methyl]phenoxyl-3-[(1-methylethyl)amino]-2-propanol(E)-2-butenedioate (2:1). It is a white crystalline powder, which is readily soluble in water, methanol, ethanol, and chloroform1. It is official in USP2.
Amlodipine besylate, a long-acting calcium channel blocker, is chemically described as 3-ethyl-5-methyl(?)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylate, monobenzenesulphonate. Amlodipine besylate is a white crystalline powder. It is slightly soluble in water and sparingly soluble in ethanol3. It is official in BP4. Beta blocker plus calcium channel blocker combinations have utility in certain cardiovascular diseases like angina pectoris, myocardial infarction and hypertension. A tablet formulation containing bisoprolol fumarate and amlodipine besylate has been recently introduced on the market.
Various methods for determination of bisoprolol by fluorimetry5, 6, HPLC7?9 and densitometry10?12 are reported in literature. Also HPTLC13?16, HPLC17?22, spectrophotometry 23?28 methods are reported for determination of amlodipine alone or in combination with other drugs. But, literature survey did not reveal any method for simultaneous determination of bisoprolol and amlodipine. The aim of this study was to develop a fast, precise, accurate, rugged and robust HPLC method for simultaneous determination of bisoprolol and amlodipine in tablets. Criteria employed for assessing suitability of proposed method was cost effectiveness and speed of analysis.
A liquid chromatographic system comprising of Waters 2695 separation module and Waters 2996 PDA detector (Waters Corporation, Milford, USA) connected to Empower chromatography software for processing the data generated were used. Reference standard of bisoprolol fumarate and amlodipine besylate was kindly supplied by Indoco Remedies along with certificate of analysis, and used as received. HPLC grade acetonitrile was purchased from J. T. Baker, NJ, USA, GR grade ammonium acetate was obtained from Merck, Mumbai, India and ExcelaR grade glacial acetic acid was supplied by Qualigens Fine Chemicals, Mumbai, India. The filter used in sample preparation was mdi SY25NN which was manufactured by Advanced Microdevices (P) Ltd, Ambala, India. The combination tablets containing bisoprolol fumarate and amlodipine besylate (Concor AM, Merck) were procured from the market.
A buffer solution was prepared by adjusting the pH of 25 mM ammonium acetate solution to 5.0 with acetic acid. The mobile phase was filtered and degassed mixture of buffer pH 5.0 and acetonitrile (65:35, v/v). Luna C18-2 column, (3 ?, 50?4.6 mm) was used as stationary phase. A constant flow of 0.8 ml/min was maintained throughout the analysis. Detection was carried out using PDA detector at 230 nm.
A combined standard stock solution of bisoprolol fumarate and amlodipine besylate was prepared in methanol (200 ?g/ml). Five ml of standard stock solution was diluted to 50 ml with mobile phase to obtain a 20 ?g/ml solution of bisoprolol and amlodipine and used as working standard for assay analysis. Twenty tablets were weighed and crushed to fine powder. An accurately weighed portion of the powder equivalent to 10 mg of bisoprolol fumarate and 10 mg of amlodipine was taken in 50 ml volumetric flask, about 30 ml of methanol was added to it and flask was kept in an ultrasonic bath for 2 min with intermittent swirling. This solution was then diluted to the mark with methanol and centrifuged. Five ml of the supernatant solution was diluted to 50 ml with mobile phase and mixed. This solution was filtered through mdi SY25NN filter and used for assay analysis. Five ?l of each of working standard and sample solution were injected into the chromatograph and the peak areas were recorded. The amount of each active was computed by external standard quantification.
In order to optimize the LC separation of bisoprolol and amlodipine, initially, mobile phases of buffer and acetonitrile were used. The retention behavior of both the drugs was studied with respect to pH of buffer solution in the range of 3.0?6.8, and aqueous composition of mobile phase. Retention of both the drugs was found slightly dependant on pH of buffer (slight increase in retention with increase in pH). Bisoprolol was found relatively less sensitive to aqueous composition as against amlodipine, which was found more sensitive to aqueous composition. A ten percent increase in aqueous composition resulted in 1.6 and 3.3 times increase in retention for bisoprolol and amlodipine respectively. The buffer solution of pH 5.0 and mobile phase composition of buffer:acetonitrile (65:35) was found most appropriate for separation of bisoprolol and amlodipine on Luna C18-2 column. Flow rate was optimized based on capacity factor and column efficiency. Bisoprolol and amlodipine were well resolved in reasonable time of about 5 minutes. The retention times were 1.45 min and 3.91 min, respectively. The resolution between bisoprolol and amlodipine was 14.2. The final dilution of analytes with mobile phase helped to minimize the interference due to blank peaks. The wavelength of 230 nm was selected for the UV detection because at this wavelength there was maximum overlap of the spectra of bisoprolol and amlodipine. The peak purity of the peak due to bisoprolol and amlodipine was tested using PDA detector and were found to be pure.
To ascertain effectiveness of system suitability test, five replicate injections of freshly prepared working standard solution were injected into the chromatograph and relative standard deviation (RSD) of peak areas was calculated. The data is presented in Table 1. System suitability parameters such as tailing factor, resolution factor, capacity factor and theoretical plates of a typical chromatogram are tabulated in Table 2. Linearity (described by equation and corresponding corre-lation coefficient) was determined using five calibration levels for both the compounds (at 50-150% levels). The concentrations of calibration solutions of both the drugs were from 8 to 33 ?g/ ml. The method of linear regression was used for data evaluation. Peak area of standard compounds was plot-ted against respective concentrations. The content of actives found in the commercial brand of tablets (Concor AM, Merck) by proposed method is shown in Table 1. The low values of RSD, indicates that method is precise. Intermediate precision was studied using different column, HPLC instrument and performing the analysis on different day. The results are presented in Table 1, along with repeatability data. Sample solution injected after 24 h of preparation did not show any appreciable change in assay value. To confirm the accuracy of the proposed method, recovery experiments were carried out by standard addition technique. Three different levels of standards were added to pre-analyzed tablet samples in triplicate. The mean percentage recoveries of bisoprolol and amlodipine were 99.1% and 98.6%, respectively. The results are shown in Table 1, which indicates that the method is accurate and precise and also there is no interference due to excipients present in the tablets. To ascertain the suitability of filter used for filtering sample preparation, the aliquot of sample solution was centrifuged and another aliquot of same sample solution was filtered through SY25NN filter. The percentage assay result of filtered sample was in close agreement with result of centrifuged sample, indicating that there was no adsorption of analytes on the filter. In order to evaluate specificity and stability indicating capability of the proposed method forced degradation studies were performed. The powdered samples of tablets were exposed to acidic, alkaline, strong oxidizing, heat and UV light conditions. Also, standard of bisoprolol and amlodipine were exposed to the above stress conditions, individually and in combination with each other to identify source of degradation peaks, if any. All the exposed standards and tablet samples were then analyzed by the proposed method. The results are given in Table 3. The assay values found lowered for bisoprolol in all the degradation conditions, however in case of amlodipine the assay values found lowered in all conditions except light. The assay values of both the ingredients were found decreased significantly in case of samples exposed to strong heat. Peaks due to bisoprolol and amlodipine in the chromatogram of all exposed samples were investigated using PDA detector and were found spectrally pure. The proposed method was subjected to robustness studies with respect to change in pH of buffer (?0.2 units), change in mobile phase composition (?3%), change in column temperature (35?) and change in flow rate (?0.1 ml). The results are presented in Table 2. The method was found robust with respect to variability in above conditions.
The proposed method is fast, precise, accurate, rugged and robust for the simultaneous determination of bisoprolol and amlodipine from tablets. Hence it can be easily and conveniently adopted for the routine quality control analysis for assay as well as dissolution and content uniformity testing.
|1.||Year: 2006Month: 10 Available from: http://www.rxlist.com/cgi/generic3/bisoprolol.htm.|
|2.||The United States PharmacopoeiaYear: 200629th edRockwell, MDThe United States Pharmacopeial Convention, Inc|
|3.||Year: 2006Month: 10 Available from: http://www.rxlist.com/cgi/generic/amlod2.htm.|
|4.||The British PharmacopoeiaYear: 2005LondonBritish Pharmacopoeial Commission|
|5.||Yang XM,Wang CB. Determination of bisoprolol in Urine by fluorometryFenxi Shiyanshi (Chinese)Year: 200120545|
|6.||Braza AJ,Modamio P,Lastra CF,Marino EL. Development validation and analytical error function of two chromatographic methods with fluorimetric detection for the determination of bisoprolol and metorpolol, in human plasmaBiomed ChromatogrYear: 2002165172212474215|
|7.||Agapova NN,Vasileva E. HPLC method for determination of bisoprolol and potential impuritiesJ Chromatogr AYear: 1993654299302|
|8.||Kintz P,Lohner S,Tracqui A,Mangin P,Lugnier A,Chaumont AJ. Rapid HPLC determination of bisoprolol in human plasmaJ Anal ChemYear: 19903365179|
|9.||Buehring KU,Garbe A. Determination of the new beta blocker bisoprolol and of metorpolol, atenolol and propranolol in plasma and urine by HPLCJ Chrom Biomed ApplYear: 19865521524|
|10.||Krzek J,Kwiecien A. Application of densitometry for determination of beta-adrenergic-blocking agents in pharmaceutical preparationsJ Planar Chromatogr Mod TLCYear: 20051830813|
|11.||Witek A,Hopkala H,Matysik G. TLC densitometric determination of bisoprolol labetolol and propafenone as dabsyl derivatives in pharmaceutical preparationsChromatographiaYear: 199950414|
|12.||Witek A,Hopkala H,Przyborowski L. Chromatographic separation of bisoprolol labetolol and propafenone, in the form of dabsyl derivativesChemia Analityczna (Warsaw)Year: 19984381722|
|13.||Meyyanathan SN,Suresh B. HPTLC method for the simultaneous determination of amlodipine and benazepril in their formulationsJ Chromatogr SciYear: 20054373515826364|
|14.||Gawri N,Vaidhyalingam V,Santha A. HPTLC method for the simultaneous estimation of amlodipine besylate and benazepril HCl tabletsIndian DrugsYear: 2003406458|
|15.||Ilango K,Kumar PB,Lakshmi KS. Simple and rapid HPTLC estimation of amlodipine and atenolol from pharmaceutical dosagesIndian DrugsYear: 2000374979|
|16.||Argekar AP,Powar SG. Simultaneous determination of atenolol and amlodipine in tablets by HPTLCJ Pharm Biomed AnalYear: 20002111374210708397|
|17.||Rao JR,Kadam SS,Mahadik KR. Reverse phase HPLC determination of amlodipine and benazepril HCl in tabletsIndian DrugsYear: 20023937881|
|18.||Gowri N,Vidhyalingam V,Santha A. Simultaneous estimation of amlodipine and benazepril from tablet by RP- HPLCIndian DrugsYear: 2001383325|
|19.||Zarapkar SS,Kanyawar NS. Simultaneous estimation of amlodipine and losartan potassium in pharmaceutical dosage by RP-HPLCIndian DrugsYear: 2002393413|
|20.||Zarapkar SS,Kolte SS,Rane SH. High performance liquid chromatographic determination of amlodipine and atenolol simultaneously from pharmaceutical preparationsIndian DrugsYear: 1997343503|
|21.||Dhorda UJ,Shetkar NB. Reverse phase HPLC determination of ramipril and amlodipine in tabletsIndian DrugsYear: 19993663841|
|22.||Halkar UP,Bhandari NP,Rane SH. High performance liquid chromatographic Simultaneous determination of amlodipine and enalapril maleate from pharmaceutical preparationsIndian DrugsYear: 1998351689|
|23.||Meyya SN,Nathan GV,Ramasarma ,Suresh B. Simultaneous spectrophotometric estimation of benazepril and amlodipine besylate in their dosage formIndian PharmacistYear: 200321001|
|24.||Prasad CVN,Parihar C,Chowdhary TR,Purohit S,Parimoo P. Simultaneous determination of atenolol-amlodipine and haloperidol-trihexyphenidyl in combined tablet preparations by derivative spectroscopyPharm Pharmacol CommYear: 1998432530|
|25.||Prasad CVN,Saha RN,Parimoo P. Simultaneous determination of amlodipine-enalapril maleate and amlodipine-lisinopril in combined tablet preparations by derivative spectrophotometryPharm Pharmacol CommYear: 199953838|
|26.||Dake AS,Kasture VS,Syed MR. Spectrophotometric estimation of amlodipine besylate and enalapril maleate in tabletIndian DrugsYear: 200239147|
|27.||Jain HK,Agrawal RK. Spectrophotometric method for simultaneous estimation of amlodipine besylate and lisinopril in tabletIndian DrugsYear: 20003719699|
|28.||Mashru RC,Parikh PP. Development of method of simultaneous estimation of amlodipine besytale and lisinopril in their in combined dosage formEast PharmYear: 2000431112|
METHOD VALIDATION RESULTS FOR INDIVIDUAL COMPOUND
|System precisiona (% RSD)||0.5||0.8|
|Repeatabilityb (% assay)||98.5||99.9|
|Repeatabilityc (% RSD)||0.3||0.4|
|Intermediate precisionb (% assay)||99.5||99.9|
|Intermediate precisionc (% RSD)||0.5||0.4|
|Linearityd (correlation coefficient)||0.99999||0.99999|
|Linearityd (equation)||y = 8922.1?||y = 14126.9?|
|- 1466.6||- 5056.6|
|Accuracye (% RSD)||0.8||0.4|
|Accuracye (% recovery)||99.1||98.6|
aDetermined on five replicate injections of working standard solution.
bDetermined on six real samples of Concor AM tablets and average is reported.
cPercent RSD of six values of% assay of Concor AM tablets.
dDetermined at five levels, from 50-150% of working standard concentration.
eDetermined at three levels with triplicate determination at each level. Mean of 9 values and% RSD is reported.
fDemonstrated by forced degradation and peak purity of main peaks in degraded samples.
gPercent correlation of assay after 24 h of sample preparation against freshly prepared sample.
hPercent correlation of assay of filtered sample against assay of centrifuged sample.
SYSTEM SUITABILITY PARAMETERS AND ROBUSTNESS
|Bisoprolol||No change (repeatability)||1.08||1.48||-||2596||98.5|
|Organic in mobile phase (+3%)||1.20||1.38||-||1522||98.4|
|Organic in mobile phase (-3%)||1.31||1.39||-||1928||98.8|
|pH of buffer (+0.2 units)||1.18||1.50||-||2524||98.5|
|pH of buffer (-0.2 units)||1.14||1.41||-||2770||98.5|
|Column temperature 35?||1.31||1.39||-||3217||98.3|
|Flow (+0.1 mL)||1.05||1.52||-||2733||98.1|
|Flow (-0.1 mL)||1.20||1.43||-||2628||98.4|
|Amlodipine||No change (repeatability)||4.58||1.53||14.23||4985||99.9|
|Organic in mobile phase (+3%)||3.79||1.54||9.23||3545||100.3|
|Organic in mobile phase (-3%)||5.25||1.52||13.26||4618||99.7|
|pH of buffer (+ 0.2 units)||4.53||1.52||13.24||4835||99.8|
|pH of buffer (- 0.2 units)||4.42||1.50||13.71||5062||99.8|
|Column temperature 35?||4.96||1.51||14.61||5614||99.4|
|Flow (+ 0.1 mL)||3.92||1.50||12.16||4738||99.1|
|Flow (- 0.1 mL)||4.29||1.55||12.65||4933||99.6|
aCapacity factor determined for individual peak.
bTailing factor determined for individual peak.
cResolution factor determined between bisoprolol and amlodipine peaks.
dColumn efficiency expressed as number of theoretical plates for bisoprolol and amlodipine peaks.
FORCED DEGRADATION DATA
|% Assay||Purity anglea||Purity threshold||% Assay||Purity anglea||Purity threshold|
|No degradation (Control)||98.5||1.177||1.598||99.9||0.480||1.278|
|Acid hydrolysis (1N HCl, 80?, 20 min)||95.3||1.191||1.357||94.1||0.380||0.981|
|Alkali hydrolysis (1N NaOH, 80?, 10 min)||95.4||0.725||1.421||93.9||0.406||0.942|
|Oxidation (30% H2O2, 80?, 30 min)||91.5||1.327||1.478||91.6||0.417||0.974|
|Thermal (105?, 1 d)||79.7||3.501||26.787||84.6||1.126||18.860|
|Photolytic (UV@254 nm, 1 d)||93.9||1.791||29.484||98.5||0.845||20.924|
aFor the peak to be pure, purity angle is required to be less than purity threshold.
Keywords: Bisoprolol fumarate, amlodipine besylate, RP-HPLC.
Previous Document: Formulation and evaluation of exotic fat based cosmeceuticals for skin repair.
Next Document: Towards a framework for the elicitation of dilemmas.